Premium
Antibodies to epstein‐barr virus, cytomegalovirus, and australia antigen in hodgkin's disease
Author(s) -
Langenhuysen M. M. A. C.,
Cazemier T.,
Houwen B.,
Brouwers Th. M.,
Halie M. R.,
The T. H.,
Nieweg H. O.
Publication year - 1974
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(197408)34:2<262::aid-cncr2820340207>3.0.co;2-h
Subject(s) - medicine , cytomegalovirus , antibody , virus , immunology , epstein–barr virus , titer , disease , immunofluorescence , antigen , virology , betaherpesvirinae , herpesviridae , indirect immunofluorescence , antibody titer , viral disease , pathology
Antibodies to Epstein‐Barr virus and cytomegalovirus, determined by an indirect immunofluorescence technique, were found to be significantly elevated in sera of untreated patients with Hodgkin's disease, as opposed to sera of age‐ and sex‐matched healthy controls. Significantly higher titers were also found in subgroups with clinically advanced disease. This pattern did not hold for histologic subclasses, as significant antibody elevations occurred only in the prognostically favorable types. Australia antibody was demonstrated by counter‐electrophoresis in four patients but in none of the controls. The prevalence of the various antibodies might be explained by a humoral hyper‐reactivity secondary to a cellular immunologic deficiency. The results presented cast some doubt on a specific role of Epstein‐Barr virus in Hodgkin's disease.